<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02246556</url>
  </required_header>
  <id_info>
    <org_study_id>14-14212</org_study_id>
    <secondary_id>093955</secondary_id>
    <nct_id>NCT02246556</nct_id>
  </id_info>
  <brief_title>Dichoptic Virtual Reality Therapy for Amblyopia in Adults</brief_title>
  <official_title>Dichoptic Virtual Reality Therapy for Amblyopia in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a randomized, masked, controlled study of the effect of a virtual reality,&#xD;
      binocular, 3-dimensional video game on visual acuity and stereopsis in adult patients with&#xD;
      amblyopia. The trial has been halted as of June 2016 and will not be evaluating any new&#xD;
      subjects for enrollment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment inadequate and investigators leaving the study institution for new positions.&#xD;
  </why_stopped>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual acuity</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in stereopsis</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Amblyopia</condition>
  <condition>Anisometropia</condition>
  <condition>Strabismus</condition>
  <arm_group>
    <arm_group_label>Patching therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patching treatment followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dioptic (non-dichoptic) therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dioptic (non-dichoptic) therapy followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dichoptic therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dichoptic virtual reality video game treatment using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dichoptic therapy</intervention_name>
    <description>Dichoptic virtual reality video game therapy with Diplopoia (TM) software developed for the Oculus Rift (R) gaming system</description>
    <arm_group_label>Dichoptic therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patching therapy</intervention_name>
    <description>Conventional patching therapy followed by crossover to the dichoptic virtual reality video game therapy with Diplopia (TM) software</description>
    <arm_group_label>Patching therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dioptic (non-dichoptic) therapy</intervention_name>
    <description>Dioptic (non-dichoptic) video game therapy followed by crossover to the dichoptic virtual reality video game therapy with Diplopia (TM) software</description>
    <arm_group_label>Dioptic (non-dichoptic) therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Interpupillary distance of 60-66 mm&#xD;
&#xD;
          -  Age 15-40&#xD;
&#xD;
          -  Anisometropic amblyopia or strabismic amblyopia&#xD;
&#xD;
          -  Best corrected visual acuity of 20/30 or worse in the amblyopic eye&#xD;
&#xD;
          -  No prior therapeutic use of the software&#xD;
&#xD;
          -  No other ongoing therapies including patching or recent eye muscle surgery&#xD;
&#xD;
          -  No vested interest in the product&#xD;
&#xD;
          -  Ability attend visits and complete the training session, and to stop the intervention&#xD;
             after the specified intervention period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Stimulus-deprivation amblyopia.&#xD;
&#xD;
          -  Organic lesions of the eye preventing the establishment of good vision (eg. media&#xD;
             opacities, abnormalities in the fundus or optic nerve).&#xD;
&#xD;
          -  Lesions of the brain preventing the establishment of good vision (eg. cortical visual&#xD;
             impairment).&#xD;
&#xD;
          -  Establishment of normal vision by refractive adaptation (wearing glasses after&#xD;
             presentation).&#xD;
&#xD;
          -  Patients diagnosed with Photosensitive Epilepsy.&#xD;
&#xD;
          -  Inability to comply with the follow-up visits required.&#xD;
&#xD;
          -  History of pathologic nystagmus (congenital or sensory).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>September 17, 2014</study_first_submitted>
  <study_first_submitted_qc>September 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2014</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Marc Levin</investigator_full_name>
    <investigator_title>Assistant Professor, Neuro-ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Amblyopia</keyword>
  <keyword>Dichoptic</keyword>
  <keyword>Virtual reality</keyword>
  <keyword>Stereopsis</keyword>
  <keyword>Stereo vision</keyword>
  <keyword>Visual acuity</keyword>
  <keyword>Binocular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
    <mesh_term>Strabismus</mesh_term>
    <mesh_term>Anisometropia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

